undamentalytics Newsletter
Sign in

Rentokil Initial PLC (RTO) stock

Add to watchlist

Add holding +

NYSE: RTO NYSE Diversified Support Services

C+ Fundamentals grade

Rentokil Initial PLC is a US-listed company in the diversified support services industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$13

Valuation models combined (4)

Base case. Range ~$9.5–$18. Weighted average of 4 models (price-to-earnings vs peers, residual income, justified price-to-book, revenue-to-maturity model), the price-to-earnings vs peers counting double.

Price vs value

Overvalued

The price is above our entire value range; our base value is 44% below it.

Price used: $24.07, November 2, 2026

Rentokil Initial PLC valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds154 adding, 129 cuttingOf 30 active managers that changed their stake, 17 added; quarter to June 30, 2026Fund buyers and sellers

The Fundamentalytics view

Rentokil Initial PLC's trailing-twelve-month revenue grew 4.4% year on year, with a free-cash-flow margin of 11.1%.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

Nothing in Rentokil Initial PLC's latest figures clears our strength thresholds.

Things to watch

  • Priced above our value. The share price of $24.07 is 44% above our value per share of $13.

Price chart

  • 1 day+3.2%
  • 1 week+6.5%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$6.9B
Operating margin
8.5%
Net margin
6.8%
EPS (TTM, diluted)
$0.93

Growth

Revenue growth
+4.4%
Change in growth rate
+0.8 pts
Share count change
+0.3%

Cash

Free cash flow (TTM)
$764M
FCF margin
11.1%

News & updates

Updated November 2, 2026

Company announcements, filed results and changes that matter to shareholders.

No recent updates are available for RTO from the sources we follow. See filings →

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Rentokil Initial PLC valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03
Sell12-month view
12-month price target
~$13
Price used
$23.71close November 3, 2026
Implied change
▼ 43%
Uncertainty
Medium

How we got here: the combined value of 4 valuation models built for a business like Rentokil Initial PLC (see the models table below and how they are combined) , with a 8.56% cost of equity. The models span ~$9.5–~$18; that spread sets a 25% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Valuation models

We value Rentokil Initial PLC as an operating company, with every model that fits that kind of business. Cost of equity 8.6%: the 10-year Treasury yield (4.9%) plus a beta of 0.81 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. ~$18 ~$15–$38 Primary model, counts double
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$11 ~$7.9–$15 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$11 ~$9.1–$13 Included
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$9.5 ~$5.8–$15 Included
Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. — Does not apply: earnings are positive: price-to-earnings is the better measure
Combined value Weighted average of the models that apply: the primary model (price-to-earnings vs peers) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$13 ~$9.5–$18 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Rentokil Initial PLC with Diversified Support Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current — — $7.2bn +5%
Next — — $7.5bn +3%

Analyst recommendations

4 analysts, Nov 2026
Buy375%
Hold125%
Sell00%

Monthly trend

  1. Nov 20261214
  2. Oct 20261214

Counts of recommendations published by analysts covering Rentokil Initial PLC, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
0.7%
of tradable shares
Days to cover
1.46
at average volume
Short interest, 1 month
−4%
to October 15, 2026
Held by institutions
15%
of shares
Held by insiders
0.0%
of shares
Employees
63,388
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

Price behaviour

52-week range
Not enough history
From 52-week high
—
vs 50-day average
—
vs 200-day average
—
Volatility (1 year)
—
Beta vs S&P 500
—

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Options strategies

All options ideas

How Rentokil Initial PLC’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: rated Sell.

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: no liquid put and call pair for the same expiry.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Rentokil Initial PLC in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 20-F, 20-F/A. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Rentokil Initial took in during FY2025, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.

  1. Revenue $6.9B
  2. Other operating costs $6.3B · 91.5%
  3. Operating income $584M · 8.5%
  4. Income tax $100M · 1.4%
  5. Net income $470M · 6.8%

Shares of revenue. Source: Rentokil Initial's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025
Income
Revenue 3,596 4,070 4,595 6,385 6,617 6,908
Operating income 377 478 392 727 644 584
Net income 239 362 287 474 392 470
Diluted EPS $0.64 $0.97 $0.71 $0.94 $0.78 $0.93
Growth (year on year)
Revenue — +13.2% +12.9% +39.0% +3.6% +4.4%
Operating income — +26.6% −17.9% +85.4% −11.4% −9.3%
Net income — +51.7% −20.7% +65.1% −17.3% +19.9%
Diluted EPS — +51.6% −26.6% +31.7% −17.3% +19.5%
Margins
Operating margin 10.5% 11.7% 8.5% 11.4% 9.7% 8.5%
Net margin 6.6% 8.9% 6.2% 7.4% 5.9% 6.8%
Free-cash-flow margin 14.9% 14.7% 12.0% 11.1% 9.8% 11.1%
Cash flow
Cash from operations 703 775 742 916 868 972
Capital spending 167 176 189 207 219 208
Free cash flow 536 599 553 709 649 764
Balance sheet
Cash — 902 2,621 1,989 1,158 2,319
Total debt — 3,389 7,924 4,016 6,249 8,897
Net debt (negative = net cash) — 2,487 5,303 2,027 5,091 6,578
Diluted shares 373m 373m 403m 505m 506m 507m
Returned to shareholders
Dividends — 191 151 252 292 304
Total returned — 191 151 252 292 304

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Older annual columns retain the reporting standard and currency used in those filings, translated separately to USD. Current filings replace overlapping periods. Reporting changes can affect comparability; older bases are not used to fill current valuation inputs.

Dividends, buybacks and capital spending

Dividends (TTM)
$304M
Returned to shareholders
40%
of free cash flow
Diluted share count
+0.3%
year over year
Dividend payout ratio
65%
of net income paid out
Days sales outstanding
61 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in diversified support services
Last 12 months unless stated RTO TRI BCO RBA CPRT CTAS Median
Revenue, last 12 months $6.9bn $7.5bn $5.5bn $4.8bn $4.7bn $11.6bn $906m
Revenue growth, last 12 months 4.4% 3.0% 8.1% 9.7% 0.4% 9.5% 6.3%
Revenue growth, 3-year average — — 5.0% 25.1% 6.4% 8.7% 6.4%
Revenue growth, latest quarter — — 7.1% 11.1% 2.4% 10.9% 7.2%
Gross margin — — 26.4% 45.6% 45.7% 51.0% 29.0%
Operating margin 8.5% 28.5% 10.5% 16.0% 35.4% 23.4% 4.9%
Operating margin, 3-year average — 22.5% 9.8% 16.6% 36.3% 22.7% 9.9%
Net margin 6.8% 20.1% 3.3% 10.0% 31.8% 17.8% 2.7%
Cash from operations / revenue 14.1% 35.5% 10.2% 17.8% 34.4% 21.1% 7.1%
Free-cash-flow margin 11.1% 27.0% 7.2% 12.6% 27.2% 17.6% 3.7%
Free-cash-flow margin, 3-year average — 25.2% 7.2% 15.5% 25.4% 17.4% 7.4%
Stock pay / revenue — — 0.5% 1.2% 0.8% 1.1% 1.4%
Change in share count 0.3% −0.4% −4.4% 0.6% −2.1% −1.2% 0.1%

Median of all 32 companies we cover in diversified support services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

32 diversified support services companies
Measure Company Peer median Rank
Revenue growth Growth 4.4% 6.5% 21 of 32
Change in growth rate Growth +0.8pp +0.8pp 17 of 32
Operating margin Profitability 8.5% 4.5% 12 of 29
Net margin Profitability 6.8% 3.3% 9 of 32
Free-cash-flow margin Cash generation 11.1% 4.1% 11 of 31
Change in share count Balance sheet 0.3% -0.1% 16 of 28
Days sales outstanding Balance sheet 61 days 60 days 15 of 26

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$2.2B
Institutions reporting
283
Shares held vs prior quarter
▲ 5.9%
Positions opened / closed
42 / 40

Top buyers and sellers, Q2 2026: 154 institutions bought and 129 sold ; the biggest buyer was Blackrock, Inc (+993K shares) and the biggest seller D. E. Shaw & Co., Inc (−439K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Jupiter Topco LLC $485M 17.0M 21.8% —
Blackrock, Inc. $356M 12.4M 16.0% ▲ 8.7%
Bank Of America Corp $192M 6.7M 8.6% ▲ 0.9%
Gates Capital Management, Inc. $148M 5.2M 6.6% ▲ 18.9%
Envestnet Asset Management Inc $73.2M 2.6M 3.3% ▲ 6.0%
Schroder Investment Management Group $67.1M 2.3M 3.0% ▲ 10.6%
River Road Asset Management, LLC $52.6M 1.8M 2.4% ▼ 3.7%
Snyder Capital Management L P $52.1M 1.8M 2.3% ▲ 6.5%
Aristotle Capital Management, LLC $48.4M 1.7M 2.2% ▼ 5.8%
Summitry LLC $40.7M 1.4M 1.8% ▼ 2.9%
Diamond Hill Capital Management, LLC (Investment Advisor) $29.7M 1.0M 1.3% ▲ 63.6%
Nichols & Pratt Advisers LLP $28.7M 1.0M 1.3% ▲ 0.5%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Rentokil Initial PLC's complete shareholder register. Values are as reported by the filers ; 2 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 3 trades and filings

No trades in Rentokil Initial PLC disclosed in the last 12 months; 3 earlier trades on record.

  • Daniel S. Goldman(D-NY 10):Sale (full), $15,001 - $50,000, traded July 10, 2023, filed August 13, 2023
  • Daniel S. Goldman(D-NY 10):Purchase, $1,001 - $15,000, traded March 31, 2023, filed April 17, 2023
  • Daniel S. Goldman(D-NY 10):Sale (partial), $15,001 - $50,000, traded February 27, 2023, filed March 20, 2023

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Recent SEC filings

Data status

When each part of this page on Rentokil Initial PLC was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Rentokil Initial PLC in brief

What does Rentokil Initial PLC do?
Rentokil Initial PLC is a US-listed company in the diversified support services industry. Its financial year ends in December.
What is Rentokil Initial PLC's stock ticker?
Rentokil Initial PLC trades under the ticker RTO on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Rentokil Initial PLC's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Rentokil Initial PLC reported revenue of $6.9B, 4.4% higher than a year earlier, according to its SEC filings.
What is Rentokil Initial PLC's free cash flow?
Rentokil Initial PLC's free-cash-flow margin is 11.1% of revenue over the trailing twelve months, ranking 11 of the 31 diversified support services companies we cover.
Who are Rentokil Initial PLC's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Jupiter Topco LLC, Blackrock, Inc. and Bank Of America Corp. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Does Rentokil Initial PLC pay a dividend?
Yes: Rentokil Initial PLC paid $304M in dividends over the trailing twelve months and a payout ratio of 64.7%.
Who are Rentokil Initial PLC's competitors?
In our Diversified Support Services peer group, the companies closest to Rentokil Initial PLC are Thomson Reuters Corp, Brinks Co, RB Global Inc., Copart and Cintas. The side-by-side comparison below sets their revenue, margins and growth against Rentokil Initial PLC's.